Violation Tracker Parent Company Summary
Parent Company Name:
Boston Scientific
Ownership Structure:
publicly traded (ticker symbol BSX)
Headquartered in:
Massachusetts
Major Industry:
medical equipment and supplies
Specific Industry:
medical devices
Penalty total since 2000:
$541,074,202
Number of records:
15
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
|---|---|---|
| safety-related offenses | $416,838,185 | 8 |
| government-contracting-related offenses | $101,650,000 | 2 |
| employment-related offenses | $15,200,000 | 2 |
| competition-related offenses | $7,040,000 | 1 |
| financial offenses | $277,017 | 1 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
|---|---|---|
| drug or medical equipment safety violation | $416,750,000 | 4 |
| False Claims Act and related | $101,650,000 | 2 |
| benefit plan administrator violation | $15,200,000 | 2 |
| price-fixing or anti-competitive practices | $7,040,000 | 1 |
| economic sanction violation | $277,017 | 1 |
Notes:
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Associated Names:
BOSTON SCIENTIFIC; ENDOVASCULAR TECH; Guidant
Links:
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year | Agency |
Penalty Amount |
|---|---|---|---|---|
| Guidant LLC | drug or medical equipment safety violation | 2011 | FDA | $296,000,000 |
| Endovascular Technologies Inc. | False Claims Act and related | 2003 | DOJ_CIVIL | $92,400,000 |
| Boston Scientific Corp. | drug or medical equipment safety violation | 2005 | USAO | $74,000,000 |
| Boston Scientific Corp. | drug or medical equipment safety violation | 2013 | FDA | $30,000,000 |
| Guidant Corporation | drug or medical equipment safety violation | 2007 | MULTI-AG | $16,750,000 |
| Guidant LLC | False Claims Act and related | 2011 | DOJ_CIVIL | $9,250,000 |
| Boston Scientific Corporation | benefit plan administrator violation | 2010 | private lawsuit-federal | $8,200,000 |
| Boston Scientific Corporation | price-fixing or anti-competitive practices | 2003 | FTC | $7,040,000 |
| Guidant Corporation | benefit plan administrator violation | 2010 | private lawsuit-federal | $7,000,000 |
| Guidant Corporation | economic sanction violation | 2007 | OFAC | $277,017 |
| BOSTON SCIENTIFIC CORPORATION | environmental violation | 2013 | EPA | $69,000 |
| BOSTON SCIENTIFIC | aviation safety violation | 2016 | FAA | $50,000 |
| BOSTON SCIENTIFIC NEUROMODULATION CORPORATION | workplace safety or health violation | 2016 | OSHA | $18,560 |
| BOSTON SCIENTIFIC | workplace safety or health violation | 2003 | OSHA | $13,100 |
| BOSTON SCIENTIFIC | workplace safety or health violation | 2003 | OSHA | $6,525 |
